Early results of chemotherapy in patients with non-small cell lung cancer
Zukowska, H.; Zwoliński, J.
Pneumonologia i Alergologia Polska 64(11-12): 774-779
1996
ISSN/ISBN: 0867-7077 PMID: 9162322 Document Number: 456901
59 patients with non-small cell lung cancer were treated with cisplatin (60 mg/m2) on day 1 and etoposide (60 mg/m2) on days 1-5. The results of the treatment were evaluated after 4th course. Remissions were seen in 27 patients, 17 patients had stabilization and 15-progression. The response rate in stages I and II was 70%, in stage III-40% and in stage IV-23%. In squamous cell carcinoma the response rate was 55%, in large cell carcinoma-25% and in adenocarcinoma-12%.
Document emailed within 1 workday
Related Documents
Grants, E.A.; Berzinia, V.I.; Bashko, I.I.; Zitare, I.I.; Berzin'sh, I.A. 1989: The results of the adjuvant chemotherapy of patients with small-cell lung cancer Voprosy Onkologii 35(2): 172-174Wiatr, E.; Bestry, I.; Dańczak-Ginalska, Z.; Starzyńska, T.; Zych, J.; Rowińska-Zakrzewska, E. 1995: The role of radiotherapy in combined treatment of limited small cell lung cancer in relation to results of induction chemotherapy Pneumonologia i Alergologia Polska 63(7-8): 421-426
Furmanik, F.; Paprota, K.; Karczmarek-Borowska, B.; Budny, B.; Sawicki, M.; Korobowicz, E.; Zdunek, M.łg.; Jabłonka, A.; Jabłonka, S.ła. 2002: Late results of the combined treatment with the use of preoperative chemotherapy and surgery of locally advanced non-small cell lung cancer Pneumonologia i Alergologia Polska 70(1-2): 34-43
Ziske, C.; Gorschlüter, M.; Mey, U.; Offergeld, R.; Glasmacher, A.; Schmidt-Wolf, I.G.H. 2002: Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer Anticancer Research 22(6b): 3723-3726
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Daido, K.; Arita, K.; Kohjima, N.; Sakamoto, N.; Sugihara, M.; Ishii, N. 1997: Investigation of chemotherapy combined with peripheral blood stem cell transplantation (PBSCT) both in elderly and in recurred patients with small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 883-887
Singer, Z.; Dzieza-Lalowicz, I.; Cieśla, J.; Kozaczka, A.; Rozek, K. 1986: Treatment of patients with small-cell lung cancer by the method of chemotherapy combined with Co-60 irradiation Polski Tygodnik Lekarski 41(23): 747-749
Cao, Y.F.; Xu, C.W.; Liao, M.L.; Fang, M.S.; Yang, X.F.; Wu, S.Z.; Chen, Y.R.; Wu, S.F.; Huang, O.L.; Wu, S.C. 1986: Chemotherapy combined with selective resection in small cell lung cancer--analysis of 239 patients Zhonghua Zhong Liu Za Zhi 8(5): 381-385
Cigolari, S.; Curcio, C.; Maiorino, A.; Sessa, R.; Cioffi, A.; Massimo, M. 2003: Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study Anticancer Research 23(2c): 1803-1809
Fram, R.; Skarin, A.; Balikian, J.; Amato, D.; Leslie, N.; Malcolm, A.; Frei, E. 1985: Combination chemotherapy followed by radiation therapy in patients with regional stage IIi unresectable non-small cell lung cancer Cancer Treatment Reports 69(6): 587-590
Ardizzoni, A.; Pennucci, C.; Fusco, V.; Gulisano, M.; Bonavia, M.; Pronzato, P.; De Palma, M.; Serrano, J.; Rosso, R. 1989: Oral chemotherapy for poor risk small-cell lung cancer patients with combined idarubicin and etoposide Anticancer Research 9(4): 937-939
Abou-Mourad, Y.; Otrock, Z.K.; Makarem, J.A.; Kattan, J.G.; Farhat, F.S.; Jalloul, R.; Mokaddem, W.T.; Ghosen, M.G.; Taher, A.T.; Chehal, A.A.; Shamseddine, A.I. 2008: Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study Le Journal Medical Libanais. Lebanese Medical Journal 56(1): 16-21
Karnaoukhova, L.; Moffat, J.; Martins, H.; Glickman, B. 1997: Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy Cancer Research 57(19): 4393-4407
Mencoboni, M.; Bergaglio, M.; Serra, M.; Ivaldi, G.P.; Tredici, S.; Racchi, O.; Rebella, L.; Galbusera, V.; Grosso, M.; Faravelli, B. 2007: Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer Anticancer Research 27(6c): 4425-4429
Aoki, T.; Yamato, Y.; Souma, T.; Yoshiya, K.; Tsuchida, M.; Watanabe, T.; Hashimoto, T.; Shinohara, H.; Hayashi, J. 1998: Results of surgical treatment in patients with T3 non-small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 51(11): 921-925
Williams, C.J.; Woods, R.; Levi, J.; Page, J. 1988: Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy Seminars in Oncology 15(6 Suppl 7: 58-61
Mańdziuk, S.ła.; Dudzisz-Sledź, M.; Korszeń-Pilecka, I.; Milanowski, J.; Wojcierowski, J.; Korobowicz, E. 2003: Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 154-157
Mori, A.; Hirose, T.; Tamura, A.; Kusaka, K.; Matsui, H.; Ohta, K. 2016: Evaluation of the Efficacy and Safety of Platinum Doublet Re-Challenge Chemotherapy in Patients with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(6): 723-726
Bianco, V.; Rozzi, A.; Tonini, G.; Santini, D.; Magnolfi, E.; Vincenzi, B.; D'Angelillo, R.; Marchei, P. 2002: Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase Ii study Anticancer Research 22(5): 3053-3056
Sato, N.; Nakamura, Y.; Kishimoto, K.; Ebina, A.; Imai, T. 2010: A phase Ii study of gemcitabine and carboplatin bi-weekly combination chemotherapy for complete resected non-small-cell lung cancer patients Kyobu Geka. Japanese Journal of Thoracic Surgery 63(10): 849-852